Arguably the most pressing question facing clinicians and patients today is not “which treatment works?” but “which treatment ...

Study estimates the global lifetime risk and benefits of modifying cardiovascular risk factors like hypertension, smoking, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Transformational 2024: successfully advanced from preclinical to clinical stage companyStrengthened leadership team to drive growth and advance ...

The prevalence of U.S. adults without diabetes who filled a GLP-1 receptor agonist prescription rose from 0.1% in 2018 to 0.4 ...

A diet involving fasting on three nonconsecutive days per week yielded a 6.37 lb greater weight loss after a year than a ...

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple ...

The carnivore diet includes only meat and animal foods, claiming to improve health. Learn its potential benefits, risks, and ...

Inhaled insulin has been available for about a decade, offering a rapid-acting alternative to traditional insulin shots.

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

An A1C test is a blood draw used to diagnose and manage prediabetes and diabetes. Learn more about who needs this test and ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...